Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
8:00am - 8:45am

Registration & Breakfast

More
Showing of Streams
10:30am - 11:00am

Morning Networking Break

More
Showing of Streams
12:30pm - 1:30pm

Networking Lunch for Participants

More
Showing of Streams
3:00pm - 3:30pm

Afternoon Refreshments Break

More
Showing of Streams
5:15pm - 7:00pm

Grand Opening Reception in the MDRP Hall

More
8:00am - 8:45am 45 mins
Registration & Breakfast
8:45am - 9:00am 15 mins
Symposium A (Full Day): Fundamentals of Government Pricing Programs
Chairperson's Opening Remarks
  • Miree Lee, MS, MBA - Bio/Pharma Pricing Consultant, M.Lee Consulting LLC
8:55am - 9:00am 5 mins
Symposium B (Full Day): The A to Z Guide to Federal Supply Schedule and Government Contrating
Chairperson’s Opening Remarks
  • Ted Karnezis - Manager, Advisory, KPMG LLP
8:55am - 9:00am 5 mins
Town Hall
Chairperson’s Opening Remarks
  • Rich Holsapple, RPh - Pharmacy Services Manager, DXC Technology
9:00am - 10:30am 90 mins
Info
Symposium A (Full Day): Fundamentals of Government Pricing Programs
Medicaid Drug Rebate Program: AMP, Best Price, and URA Calculations and Manufacturer Requirements
  • Miree Lee, MS, MBA - Bio/Pharma Pricing Consultant, M.Lee Consulting LLC

This session will cover everything MDRP; Past, Present & Future and is applicable to veterans and beginners alike providing the context for current processes and challenges industry professionals are facing. Attendees will get a timeline and overview of how the Medicaid Drug Rebate program has evolved including milestone changes over the years. At the conclusion of this session, attendees will understand what the calculations are, how they are made, and answer any questions related to their completion. In addition, this session seeks to clear any confusion you might have and will walk you through the rationale behind the importance, methodologies and approaches you can use to calculate and recalculate the AMP, BP and Medicaid Unit Rebate Amount. If the AMP and/or BP confuse you, this is the session that will clear up that confusion. Questions to be addressed:

• What is AMP and BP?

• What are they used for?

• Why are they important?

• How do you calculate them and are there different methodologies?

• When are recalculations necessary?

9:00am - 10:30am 90 mins
Info
Symposium B (Full Day): The A to Z Guide to Federal Supply Schedule and Government Contrating
How to Prepare For, Negotiate, and Implement Your FSS Contract
  • Josh O'Harra - Assistant General Counsel, Eli Lilly and Company
  • Elizabeth Lindquist - Senior Associate, FDA & Life Sciences Practice Group, King & Spalding LLP

Gain insights from experienced inside and outside counsel who have recently completed FSS contract renewals. Hear about what to expect in the pre- and post-award audit process and learn best practices for conducting the cross-functional diligence necessary to compliantly contract with the Department of Veterans Affairs.

This session will also provide a comprehensive overview of the VA FSS contract for pharmaceuticals, including a discussion of key clauses, notable changes to contract terms and requirements resulting from VA Mass Modification 0006, relevant price calculations, compliance considerations, and practical operational guidance for contract negotiation and administration.

9:00am - 10:30am 90 mins
Info
Town Hall
Best Practice & Policy Ideas: An Open Dialogue Between Manufacturers and States Part 1
  • Moderator Rich Holsapple, RPh - Pharmacy Services Manager, DXC Technology
  • Panelist Maury Anderson - Director, Rebate Operations, Magellan Medicaid Administration
  • Panelist Felicia DiPaolo - Manager, Pharmacy Rebate Operations, Magellan Rx Management
  • Panelist Lisa Norton - Associate Consultant, Managed Healthcare Services, Eli Lilly and Company

Symposia participants have the option of submitting additional questions via the MDRP website leading up to the summit. In addition, Town Hall discussions are not limited to discussions and questions submitted prior to the summit, the aim of this town hall is to facilitate open conversation acting as a platform for improving collaboration between manufacturers and state rebate vendors minimizing process and operational frustrations and best practice when dealing with state drug rebate policies.

Questions to be discussed:

  • How do you process State invoices?
  • How do manufacturers decide that a drug meets the definition on a “covered out-patient drug” and gets reported on the DDR? Specifically OTC products?
  • How is the unit of measure determined? Why don’t they match what CMS has for a UOM?
  • What are your thoughts on “inner and outer” NDC-11?
  • What is your process for reporting term dates and URA information to CMS?
  • What are the rules for putting a termination on a drug? Why does it get terminated retroactively?
  • What are your termination date procedures when drug has been recalled from the market?
  • What kind of validation do you do on your CLD and how do you decide when to dispute? What information do you look for from State’s?
  • How do you feel about MCO rebates and 340B?
  • What determines which disputes are addressed first?
  • Do the people States work with have the authority to make resolution decisions?
  • What are your thoughts on disputing quarters or getting retro invoices for quarters > 2 years old?
10:30am - 11:00am 30 mins
Morning Networking Break
11:00am - 11:45am 45 mins
Info
Symposium A (Full Day): Fundamentals of Government Pricing Programs
Overview of the 340B Drug Discount Program and Pricing Calculations
  • Elizabeth Wicyk-McGovern - Senior Manager Pricing & Reimbursement, Pfizer

This session will focus on the 340B program as it impacts hospitals. There will be an overview of the program, and discussion of current research and legislative and regulatory developments.

  • Benefits and obligations of the 340B program as applied to hospitals
  • Overview of research relating to hospitals’ role in the 340B program
  • Discussion of potential impact of legislative and regulatory developments, such as HRSA’s mega-guidance proposal 
11:00am - 12:30pm 90 mins
Symposium B (Full Day): The A to Z Guide to Federal Supply Schedule and Government Contrating
Public Law Compliance
  • Stephen Ruscus - Partner, Morgan, Lewis & Bockius LLP
11:00am - 12:30pm 90 mins
Info
Town Hall
Best Practice & Policy Ideas: An Open Dialogue Between Manufacturers and States Part 2
  • Moderator Rich Holsapple, RPh - Pharmacy Services Manager, DXC Technology
  • Panelist Maury Anderson - Director, Rebate Operations, Magellan Medicaid Administration
  • Panelist Felicia DiPaolo - Manager, Pharmacy Rebate Operations, Magellan Rx Management
  • Panelist Lisa Norton - Associate Consultant, Managed Healthcare Services, Eli Lilly and Company

Symposia participants have the option of submitting additional questions via the MDRP website leading up to the summit. In addition, Town Hall discussions are not limited to discussions and questions submitted prior to the summit, the aim of this town hall is to facilitate open conversation acting as a platform for improving collaboration between manufacturers and state rebate vendors minimizing process and operational frustrations and best practice when dealing with state drug rebate policies.

Questions to be discussed:

  • What is your biggest frustration with State drug rebate policies?
  • What do you see from individual states that you would consider to be a “best practice” that other states should consider adopting?
  • How do you determine if the utilization being invoiced was 340B?
  • How do states identify 340B claims and exclude from rebates? FFS? MCO? Contract pharmacy?
  • What frustrations do you have with MCO invoices?
  • What are the thoughts and plans in regards to MCO being based on DOS? What about PAD claims that are for a DOS range?
  • Do you do electronic ROSI/PQAs? What is your format?
  • Having readable invoices and ROSI/PQAs-font size, etc.
  • Do labelers make sure to have the URA indicator on ROSIs for all NDCs paid?
11:45am - 12:30pm 45 mins
Symposium A (Full Day): Fundamentals of Government Pricing Programs
FSS Contract: The Basics of the Contract and Manufacturer Requirements
  • Elizabeth Lindquist - Senior Associate, FDA & Life Sciences Practice Group, King & Spalding LLP
12:30pm - 1:30pm 60 mins
Networking Lunch for Participants
1:30pm - 2:15pm 45 mins
Info
Symposium A (Full Day): Fundamentals of Government Pricing Programs
Medicare Part B: ASP Reporting and Compliance
  • Kathleen A. Peterson - Counsel, Hogan Lovells US LLP

This session will provide deep insight into what Medicare Part B covers, current hot topics, and how Medicare reimbursement to providers for Part B drugs operates. Average Sales Price (ASP) calculations submitted by manufacturers on a quarterly basis will be discussed along with ensuring proper calculation methodologies, auditing, and avoiding penalties associated with inaccurate or untimely ASP submissions. CMS’s recent proposal to reduce Part B reimbursement for 340B drugs will also be explored.

1:30pm - 2:15pm 45 mins
Info
Symposium B (Full Day): The A to Z Guide to Federal Supply Schedule and Government Contrating
Negotiating after Pass/Fail
  • Gregory Madden - Principal, Orlaithe Consulting LLC

An in-depth examination of the documented rationale to support proposed contract pricing and tracking customer(s) under the Price Reductions Clause; setting high and low objectives for all the FSS points of negotiation; how to break an impasse during negotiations with the Government; and best practices to reach the award stage in timely fashion.

1:30pm - 1:35pm 5 mins
Symposium C (Half Day): MDRP for the Seasoned Attendee
Chairperson's Opening Remarks
  • Christopher H. Schott - Partner, Hogan Lovells US LLP
1:30pm - 3:00pm 90 mins
Info
State Dispute Resolution Meetings
Dispute Resolution Meetings
  • Oregon Rich Holsapple, RPh - Pharmacy Services Manager, DXC Technology
  • Utah John Curless - Department of Health, Division of Medicaid and Health Financing, Bureau of Coverage and Reimbursement Policy (Utah)
  • Maryland Dorine Rascoe - Fiscal Program Manager, Drug Rebates and Lockbox Services, Office of Finance, Medical Care Programs, Maryland Department of Health (MDH)
  • Multiple Maury Anderson - Director, Rebate Operations, Magellan Medicaid Administration
  • Multiple Felicia DiPaolo - Manager, Pharmacy Rebate Operations, Magellan Rx Management
  • Indiana Eric Wilcher - Rebate Accountant, OptumRx
  • Multiple Steve Smith - St. Manager, Industry Relations, OptumRx
  • Nevada Brian Gard - Rebate Analyst, Industry Relations, OptumRx
  • Wisconsin Jodi Hettinga - Drug Rebate Analyst and Unit Lead, Wisconsin Title XIX Account, DXC Technology

Alaska

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Arizona

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Arkansas

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Colorado

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Connecticut

Patricia Bartolotta,CTMAP Drug Rebate , Drug Rebate Coordinator DXC Technology

Idaho

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Indiana

Eric Wilcher, Rebate Accountant, OptumRx

Steve Smith, Sr. Manager, Industry Relations, OptumRx

Kentucky

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Maryland

Dorine B. Rascoe,Drug Rebate Manager, DHMH/Medicaid Pharmacy Program

Michigan

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Nevada

Brian Gard, Rebate Analyst, Industry Relations, OptumRx

Steve Smith, Sr. Manager, Industry Relations, OptumRx

New Hampshire

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

North Carolina

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Oregon

Richard Holsapple, Pharmacy Services Manager, HP Enterprise Services

South Carolina

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Tennessee 

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Utah

John Curless, Department of Health, Division of Medicaid and Health Financing at Bureau of Coverage and Reimbursement Policy

Wisconsin

Jodi Hettinga, Drug Rebate Analyst and Unit Lead, Wisconsin Title XIX Account, DXC Technology

1:35pm - 2:15pm 40 mins
Info
Symposium C (Half Day): MDRP for the Seasoned Attendee
Innovative Bundling Arrangements vs. Traditional Bundling
  • Trevor Wear, J.D. - Partner, Healthcare, Sidley Austin

We will provide insights and opportunities for clarification regarding the new generic inflation penalty guidance.  We will also discuss best practices for internal assumptions based on identified gaps in the guidance from CMS to date.

2:15pm - 3:00pm 45 mins
Symposium A (Full Day): Fundamentals of Government Pricing Programs
Medicare Part D Coverage Gap: Manufacturer Requirements and CGDP Process
  • Michael Fraclose - Associate Director, Government Pricing and Contracting, Takeda Oncology
2:15pm - 3:00pm 45 mins
Info
Symposium B (Full Day): The A to Z Guide to Federal Supply Schedule and Government Contrating
Public Law Annual Reporting
  • Ted Karnezis - Manager, Advisory, KPMG LLP

Presentation will mainly focus on the compliance aspects of Public Law 102-585, Section 603.  It walks through the general process, from VA’s perspective on how to establish 2019 Federal Ceiling Prices and pricing updates for Federal Supply Schedule contracts. This presentation also highlights the differences between a “base” versus “dual” year and provides an explanation of calculations.

2:15pm - 3:00pm 45 mins
Info
Symposium C (Half Day): MDRP for the Seasoned Attendee
Panel: Partnering with Internal Departments Earlier for More Successful Estimates and Risk Profiling
  • Moderator Michael Kurland - Vice President Contracting and Government Programs, Dohmen Life Science Services
  • Panelist Srini Sripada - Senior Manager, Government Contracts & Pricing, Gilead Sciences
  • Panelist Jonathan Connell, JD, MBA - Senior Corporate Counsel, Bristol-Myers Squibb

Internal partnerships are a common challenge for Government Pricing experts. The demands of our fast-paced business necessitate consistent proactive, two-way communication. Mike Kurland leads an interactive discussion on key challenges and creative solutions for collaborative internal partnerships

3:00pm - 3:30pm 30 mins
Afternoon Refreshments Break
3:30pm - 4:15pm 45 mins
Symposium A (Full Day): Fundamentals of Government Pricing Programs
Cases within Government Programs: Where Issues Arise and What Happens Next?
  • Christopher H. Schott - Partner, Hogan Lovells US LLP
3:30pm - 4:15pm 45 mins
Info
Symposium B (Full Day): The A to Z Guide to Federal Supply Schedule and Government Contrating
Drug Coverage and Reimbursement within VA and DoD
  • Allison D. Pugsley - Partner, Hogan Lovells US LLP

This presentation will cover the topic of drug coverage and reimbursement within VA and DoD.  With more specialty products coming onto the market, the VA and DoD are not always procuring drugs/biologics in the traditional way.  This presentation will address alternative ways that VA and DoD cover and reimburse providers for drugs administered to their beneficiaries.

3:30pm - 4:15pm 45 mins
Symposium C (Half Day): MDRP for the Seasoned Attendee
Leveraging Reasonable Assumptions to Mitigate Risks
  • Debbie Walters - Vice President and Assistant General Counsel, Pfizer
3:30pm - 5:00pm 90 mins
Info
State Dispute Resolution Meetings
Dispute Resolution Meetings
  • John Curless - Department of Health, Division of Medicaid and Health Financing, Bureau of Coverage and Reimbursement Policy (Utah)
  • Rich Holsapple, RPh - Pharmacy Services Manager, DXC Technology
  • Dorine Rascoe - Fiscal Program Manager, Drug Rebates and Lockbox Services, Office of Finance, Medical Care Programs, Maryland Department of Health (MDH)
  • Maury Anderson - Director, Rebate Operations, Magellan Medicaid Administration
  • Felicia DiPaolo - Manager, Pharmacy Rebate Operations, Magellan Rx Management
  • Eric Wilcher - Rebate Accountant, OptumRx
  • Steve Smith - St. Manager, Industry Relations, OptumRx
  • Brian Gard - Rebate Analyst, Industry Relations, OptumRx
  • Jodi Hettinga - Drug Rebate Analyst and Unit Lead, Wisconsin Title XIX Account, DXC Technology

Alaska

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Arizona

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Arkansas

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Colorado

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Conneticut

Patricia Bartolotta,CTMAP Drug Rebate , Drug Rebate Coordinator DXC Technology

Delaware

Mandy Hunter, Pharmacy Services Manager, HP Enterprise Services

Idaho

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Indiana

Eric Wilcher, Rebate Accountant, OptumRx

Steve Smith, Sr. Manager, Industry Relations, OptumRx

Kentucky

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Maryland

Dorine B. Rascoe,Drug Rebate Manager, DHMH/Medicaid Pharmacy Program

Michigan

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Nevada

Brian Gard, Rebate Analyst, Industry Relations, OptumRx

Steve Smith, Sr. Manager, Industry Relations, OptumRx

New Hampshire

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

North Carolina

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Oregon

Richard Holsapple, Pharmacy Services Manager, HP Enterprise Services

South Carolina

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Tennessee 

Maury Anderson, Director, Rebate Operations, Magellan Health

Felicia DiPaolo, Supervisor, Rebate Operations, Magellan Health

Utah

John Curless, Department of Health, Division of Medicaid and Health Financing at Bureau of Coverage and Reimbursement Policy

Wisconsin

Jodi Hettinga, Drug Rebate Analyst and Unit Lead, Wisconsin Title XIX Account, DXC Technology

4:15pm - 5:15pm 60 mins
Symposium A (Full Day): Fundamentals of Government Pricing Programs
Wrap Up: Key Takeaways and Critical Points on the Different Programs
  • Miree Lee, MS, MBA - Bio/Pharma Pricing Consultant, M.Lee Consulting LLC
4:15pm - 5:00pm 45 mins
Symposium B (Full Day): The A to Z Guide to Federal Supply Schedule and Government Contrating
Presentation Title TBA
  • Stephen Ruscus - Partner, Morgan, Lewis & Bockius LLP
4:15pm - 5:00pm 45 mins
Info
Symposium C (Half Day): MDRP for the Seasoned Attendee
GP SOPs: A Practical Guide to Development and Maintenance of a Compliance Program Cornerstone
  • Megan Falkowski - Director, Government Pricing & Government Contracting Policy, Pfizer

This segment of the “MDRP for the Seasoned Attendee” workshop will provide you with a framework, methodological approach and key considerations for the development and maintenance of Standard Operating Procedures within Government Pricing department, which can be easily leveraged for or other compliance-driven departments.

5:15pm - 7:00pm 105 mins
Grand Opening Reception in the MDRP Hall